Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machteld M Zweers

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 7, 2004
Diffusion correction of sodium sieving applicable in a peritoneal equilibration testWytske M Westra, Watske Smit, Machteld M Zweers, et al.
NDT Plus|May 19, 2015
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 24, 2004
Does residual volume after drainage matter in peritoneal dialysis treatment?Alena Parikova, Machteld M Zweers, Johan K Hiralall, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 6, 2007
What can we do to preserve the peritoneum?Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 7, 2004
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysisSema Akman, Roos van Westrhenen, Dirk R De Waart, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 1, 2004
Does lymphatic absorption change with the duration of peritoneal dialysis?Wieneke M Michels, Machteld M Zweers, Watske Smit, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 10, 2009
Karl d. Nolph state of the art lecture: feasible and future options for salvation of the peritoneal membraneRaymond T Krediet, Annemieke M Coester, Inna Kolesnyk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Dextran antibodies in peritoneal dialysis patients treated with icodextrinMarissa C Aanen, Dirk R de Waart, Paul F Williams, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 26, 2011
Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failureMarijke de Graaff, Anniek Vlijm, Machteld M Zweers, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2008
A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solutionRoos van Westrhenen, Machteld M Zweers, Cindy Kunne, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 7, 2004
Diffusion correction of sodium sieving applicable in a peritoneal equilibration testWytske M Westra, Watske Smit, Machteld M Zweers, et al.
NDT Plus|May 19, 2015
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|April 24, 2004
Does residual volume after drainage matter in peritoneal dialysis treatment?Alena Parikova, Machteld M Zweers, Johan K Hiralall, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 6, 2007
What can we do to preserve the peritoneum?Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 7, 2004
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysisSema Akman, Roos van Westrhenen, Dirk R De Waart, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 1, 2004
Does lymphatic absorption change with the duration of peritoneal dialysis?Wieneke M Michels, Machteld M Zweers, Watske Smit, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 10, 2009
Karl d. Nolph state of the art lecture: feasible and future options for salvation of the peritoneal membraneRaymond T Krediet, Annemieke M Coester, Inna Kolesnyk, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Dextran antibodies in peritoneal dialysis patients treated with icodextrinMarissa C Aanen, Dirk R de Waart, Paul F Williams, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|February 26, 2011
Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failureMarijke de Graaff, Anniek Vlijm, Machteld M Zweers, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2008
A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solutionRoos van Westrhenen, Machteld M Zweers, Cindy Kunne, et al.
Pageof 3